StocksFundsScreenerSectorsWatchlists
MASS

MASS - 908 Devices Inc. Stock Price, Fair Value and News

5.79USD-0.28 (-4.61%)Market Closed

Market Summary

MASS
USD5.79-0.28
Market Closed
-4.61%

MASS Stock Price

View Fullscreen

MASS RSI Chart

MASS Valuation

Market Cap

190.5M

Price/Earnings (Trailing)

-5.23

Price/Sales (Trailing)

3.79

EV/EBITDA

-2.04

Price/Free Cashflow

-7.03

MASS Price/Sales (Trailing)

MASS Profitability

Operating Margin

50.41%

EBT Margin

-72.89%

Return on Equity

-21.99%

Return on Assets

-17.93%

Free Cashflow Yield

-14.22%

MASS Fundamentals

MASS Revenue

Revenue (TTM)

50.2M

Rev. Growth (Yr)

23.26%

Rev. Growth (Qtr)

0.38%

MASS Earnings

Earnings (TTM)

-36.4M

Earnings Growth (Yr)

24.41%

Earnings Growth (Qtr)

-4.73%

Breaking Down MASS Revenue

Last 7 days

-12.1%

Last 30 days

-13.8%

Last 90 days

-25.4%

Trailing 12 Months

-30.5%

How does MASS drawdown profile look like?

MASS Financial Health

Current Ratio

7.71

Debt/Equity

0.09

Debt/Cashflow

-1.67

MASS Investor Care

Shares Dilution (1Y)

2.11%

Diluted EPS (TTM)

-1.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202348.0M49.0M47.5M50.2M
202245.0M47.8M51.0M46.9M
202128.4M25.6M32.1M42.2M
202000026.9M

Tracking the Latest Insider Buys and Sells of 908 Devices Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
brown christopher d.
acquired
6,300
1.75
3,600
chief product officer
Mar 26, 2024
griffith joseph h. iv
acquired
13,330
1.58
8,437
chief financial officer
Mar 04, 2024
hunt anthony
acquired
-
-
2,057
-
Feb 22, 2024
eloi fenel m
acquired
-
-
508
-
Feb 22, 2024
george jeffrey p.
acquired
-
-
508
-
Feb 02, 2024
griffith joseph h. iv
sold
-68,873
7.0923
-9,711
chief financial officer
Feb 01, 2024
griffith joseph h. iv
acquired
-
-
15,409
chief financial officer
Feb 01, 2024
knopp kevin j.
sold
-63,460
6.99599
-9,071
president and ceo
Feb 01, 2024
turner michael s.
sold
-36,558
6.98752
-5,232
chief legal & admin officer
Feb 01, 2024
turner michael s.
acquired
-
-
14,337
chief legal & admin officer

1–10 of 50

Which funds bought or sold MASS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 03, 2024
Versant Capital Management, Inc
sold off
-100
-516
-
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-66.67
-53.00
67.00
-%
Mar 11, 2024
VANGUARD GROUP INC
added
1.93
8,174,220
19,571,400
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
132
472,331
634,582
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.4
49,420
122,320
-%
Feb 20, 2024
EVENTIDE ASSET MANAGEMENT, LLC
unchanged
-
6,525,340
16,055,800
0.26%
Feb 16, 2024
GSA CAPITAL PARTNERS LLP
sold off
-100
-112,000
-
-%
Feb 15, 2024
BARCLAYS PLC
added
683
313,000
338,000
-%
Feb 15, 2024
JANE STREET GROUP, LLC
reduced
-52.29
-36,996
151,469
-%
Feb 15, 2024
Legal & General Group Plc
reduced
-13.9
6,346
20,432
-%

1–10 of 45

Are Funds Buying or Selling MASS?

Are funds buying MASS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MASS
No. of Funds

Unveiling 908 Devices Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
ameriprise financial inc
5.84%
1,889,627
SC 13G
Feb 14, 2024
eventide asset management, llc
4.42%
1,430,995
SC 13G/A
Feb 14, 2024
granahan investment management, llc
6.30%
2,038,658
SC 13G
Feb 13, 2024
vanguard group inc
5.39%
1,744,330
SC 13G
Feb 09, 2024
arch venture fund vii, l.p.
17.7%
5,725,045
SC 13G/A
Jan 31, 2024
blackrock inc.
5.5%
1,786,753
SC 13G/A
Jan 29, 2024
ark investment management llc
13.42%
4,346,579
SC 13G/A
Nov 13, 2023
alger associates inc
3.8%
1,227,494
SC 13G/A
Feb 14, 2023
alger associates inc
8.8%
2,805,216
SC 13G/A
Feb 14, 2023
eventide asset management, llc
7.0%
2,230,665
SC 13G

Recent SEC filings of 908 Devices Inc.

View All Filings
Date Filed Form Type Document
Apr 02, 2024
4
Insider Trading
Mar 27, 2024
4
Insider Trading
Mar 08, 2024
10-K
Annual Report
Mar 08, 2024
S-8
Employee Benefits Plan
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
8-K
Current Report

Peers (Alternatives to 908 Devices Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
188.9B
40.1B
-5.73% 4.72%
33.01
4.71
-8.12% -17.45%
67.8B
19.5B
-0.88% -8.17%
53.97
3.48
4.02% -22.04%
22.9B
3.9B
-3.10% -11.00%
51.41
5.92
3.42% 23.09%
20.3B
14.8B
-3.77% -6.99%
7.66
1.37
2.12% 209.17%
MID-CAP
9.1B
3.5B
-1.99% 15.94%
32.07
2.62
4.97% 18.89%
9.1B
12.3B
-5.16% -14.19%
21.85
0.74
-2.44% -22.68%
8.8B
2.7B
-9.88% -37.29%
-13.77
3.29
-4.68% 82.43%
6.4B
4.0B
-5.94% -24.93%
-47.62
1.62
1.10% 85.84%
3.4B
366.4M
-0.71% 17.46%
-565.84
9.37
33.86% 89.83%
2.3B
6.6B
-6.94% -4.63%
11.73
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-3.79% -17.24%
-1.94
0.41
7.73% -1066.14%
376.4M
166.7M
-0.35% -8.55%
-4.55
2.26
6.67% -456.34%
253.5M
324.0M
17.88% -30.36%
-1.32
0.78
-3.19% -337.41%
47.8M
52.3M
-22.91% -54.00%
-2.55
0.91
17.61% 19.28%
3.8M
3.7M
-16.18% 262.50%
-0.31
1.01
5.77% 8.23%

908 Devices Inc. News

Latest updates
Seeking Alpha10 Apr 202404:49 pm
The Globe and Mail10 Apr 202402:04 pm
The Globe and Mail10 Apr 202401:27 pm
CNN12 Mar 202411:42 am
Yahoo Finance05 Mar 202408:00 am
Seeking Alpha05 Mar 202408:00 am

908 Devices Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q1
Revenue0.4%14,351,00014,297,00012,094,0009,487,00011,643,00015,797,00011,106,0008,306,00015,841,00012,545,0008,277,0005,543,0005,717,0006,048,00011,128,0004,001,000
Cost Of Revenue10.1%7,076,0006,428,0006,300,0005,103,0005,721,0006,459,0004,472,0004,177,0006,707,0005,733,0003,898,0002,635,0003,138,0002,212,0004,718,0001,903,000
Gross Profit-7.5%7,275,0007,869,0005,794,0004,384,0005,922,0009,338,0006,634,0004,129,0009,134,0006,812,0004,379,0002,908,0002,579,0003,836,0006,410,0002,098,000
Operating Expenses0.2%16,988,00016,958,00016,733,00017,401,00016,260,00016,492,00015,003,00013,650,00012,662,00012,088,00011,834,0008,718,0006,465,0005,129,0004,282,0004,862,000
  S&GA Expenses1.1%11,544,00011,421,00011,208,00012,003,00011,598,00011,826,00010,710,0009,745,0008,917,0008,786,0008,779,0005,753,0004,183,0003,178,0002,436,0002,706,000
  R&D Expenses-1.7%5,444,0005,537,0005,525,0005,398,0004,636,0004,666,0004,293,0003,905,0003,745,0003,302,0003,055,0002,965,0002,282,0001,951,0001,846,0002,156,000
EBITDA Margin-Infinity%-0.68--0.63-0.64-0.68-----------
Interest Expenses100.0%--350,000-551,00061,00033,00015,00020,00040,00031,00039,000376,000244,000245,000246,000241,000
Income Taxes110.3%9,000-87,000-71,000-------------
Earnings Before Taxes-3.5%-7,431,000-7,180,000-9,417,000---6,259,000-8,099,000---------
EBT Margin-Infinity%-0.73--0.68-0.70-0.72-----------
Net Income-4.7%-7,428,500-7,093,000-9,346,000-12,532,000-9,827,500-6,259,000-8,099,000-9,415,000-3,465,000-5,185,000-7,424,000-6,095,000-10,226,000-1,722,0002,095,000-2,966,000
Net Income Margin11.2%-0.72-0.82-0.77-0.76-0.72-0.53-0.55-0.57-0.53-0.90-1.00-0.56----
Free Cashflow52.9%-2,263,000-4,807,000-8,202,000-11,832,000-5,728,000-5,682,000-10,482,000-1,083,000-9,274,000-2,982,000-7,921,000-9,642,000----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Assets-2.6%203208211218243249247251261166166172179
  Current Assets-3.4%174180181188216224239243253157157163171
    Cash Equivalents2.5%121118133161188194213223224139141149159
  Inventory-6.2%15.0016.0014.0013.0013.0012.0011.0010.008.008.008.007.005.00
  Net PPE17.1%3.003.003.003.003.003.002.002.002.002.002.001.001.00
  Goodwill4.8%10.0010.0010.0010.0010.009.00-------
Liabilities-2.7%37.0039.0036.0038.0052.0053.0046.0044.0046.0044.0040.0038.0040.00
  Current Liabilities1.0%23.0022.0020.0019.0019.0019.0015.0014.0015.0013.0011.009.0011.00
  Long Term Debt-----15.0015.0015.0015.0015.0015.0015.0015.0014.00
    LT Debt, Non Current-----15.0015.0015.0015.0015.0015.0015.0015.0014.00
Shareholder's Equity-2.6%165170174181191197201207215123127133139
  Retained Earnings-4.6%-170-163-156-146-134-124-118-110-100-97.20-91.99-84.60-78.47
  Additional Paid-In Capital0.8%335332329326324321319317315220219218217
Shares Outstanding0.5%33.0032.0032.0032.0032.0032.0031.0031.0031.0028.0027.0027.00-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q1
Cashflow From Operations58.0%-1,930-4,600-7,882-10,647-5,116-4,938-10,410-466-9,220-2,924-7,305-9,6332,3328,197-3,230-3,168
  Share Based Compensation-13.5%2,3392,7042,5782,1662,0042,0201,8941,28987381148133930783.0069.0066.00
Cashflow From Investing146.8%4,636-9,915-19,936-1,185-612-14,506-72.00-617-54.00-58.00-616-9.00-175-93.00-91.00
Cashflow From Financing138.3%95.00-248-401-15,38141117146713094,532483276-566137,1835.001.003.00

MASS Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue$ 50,229$ 46,852
Cost of revenue24,90720,829
Gross profit25,32226,023
Operating expenses:  
Research and development21,90417,526
Selling, general and administrative46,17643,879
Total operating expenses68,08061,405
Loss from operations(42,758)(35,382)
Other income, net:  
Interest income6,4802,031
Interest expense(201)(129)
Other expense, net(131)(83)
Total other income, net6,1481,819
Loss from operations before income taxes(36,610)(33,563)
Benefit for income taxes2110
Net loss$ (36,399)$ (33,563)
Net loss per share, basic$ (1.13)$ (1.07)
Net loss per share, diluted$ (1.13)$ (1.07)
Weighted average common shares outstanding, basic32,239,39431,492,531
Weighted average common shares outstanding, diluted32,239,39431,492,531
Product revenue  
Revenue$ 40,214$ 37,499
Cost of revenue18,42816,010
Service revenue  
Revenue9,6456,976
Cost of revenue6,3804,420
Contract revenue  
Revenue3702,377
Cost of revenue$ 99$ 399

MASS Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 121,041$ 188,422
Marketable securities24,641 
Accounts receivable, net of allowance for credit losses of $395 and $25 at December 31, 2023 and December 31, 20228,98910,033
Inventory14,93812,513
Prepaid expenses and other current assets4,1814,658
Total current assets173,790215,626
Operating lease, right-of-use assets6,2333,956
Property and equipment, net3,3423,083
Goodwill10,36710,050
Intangible assets, net7,8608,488
Other long-term assets1,3891,384
Total assets202,981242,587
Current liabilities:  
Accounts payable1,1911,397
Accrued expenses8,7138,847
Deferred revenue10,6297,514
Operating lease liabilities2,0161,468
Total current liabilities22,54919,226
Long-term debt 15,000
Operating lease liabilities, net of current portion3,9293,040
Deferred revenue, net of current portion8,57111,496
Deferred income taxes2,4412,671
Other long-term liabilities 555
Total liabilities37,49051,988
Commitments and contingencies (Note 15)
Stockholders' equity:  
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at December 31, 2023 and December 31, 2022, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 32,519,023 shares and 31,859,847 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively3332
Additional paid-in capital334,692323,969
Accumulated other comprehensive income1,365798
Accumulated deficit(170,599)(134,200)
Total stockholders' equity165,491190,599
Total liabilities and stockholders' equity$ 202,981$ 242,587
MASS
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITE908devices.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES227

908 Devices Inc. Frequently Asked Questions


What is the ticker symbol for 908 Devices Inc.? What does MASS stand for in stocks?

MASS is the stock ticker symbol of 908 Devices Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of 908 Devices Inc. (MASS)?

As of Mon Apr 15 2024, market cap of 908 Devices Inc. is 190.55 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MASS stock?

You can check MASS's fair value in chart for subscribers.

What is the fair value of MASS stock?

You can check MASS's fair value in chart for subscribers. The fair value of 908 Devices Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of 908 Devices Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MASS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is 908 Devices Inc. a good stock to buy?

The fair value guage provides a quick view whether MASS is over valued or under valued. Whether 908 Devices Inc. is cheap or expensive depends on the assumptions which impact 908 Devices Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MASS.

What is 908 Devices Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, MASS's PE ratio (Price to Earnings) is -5.23 and Price to Sales (PS) ratio is 3.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MASS PE ratio will change depending on the future growth rate expectations of investors.